diethylnitrosamine has been researched along with acetylglucosamine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bhaumik, M; Guttenplan, J; Harris, T; Johnson, L; Rogler, C; Stanley, P; Sundaram, S | 1 |
Rogler, CE; Stanley, P; Tang, J; Yang, X | 1 |
2 other study(ies) available for diethylnitrosamine and acetylglucosamine
Article | Year |
---|---|
Progression of hepatic neoplasms is severely retarded in mice lacking the bisecting N-acetylglucosamine on N-glycans: evidence for a glycoprotein factor that facilitates hepatic tumor progression.
Topics: Acetylglucosamine; Animals; Carcinogens; Diethylnitrosamine; Disease Progression; Female; Genetic Vectors; Liver Neoplasms, Experimental; Male; Mice; N-Acetylglucosaminyltransferases; Neoplasm Proteins; Phenobarbital; Polysaccharides | 1998 |
Reduced hepatocyte proliferation is the basis of retarded liver tumor progression and liver regeneration in mice lacking N-acetylglucosaminyltransferase III.
Topics: Acetylglucosamine; Animals; Apoptosis; Carbohydrate Sequence; Carcinogens; Cell Division; Diethylnitrosamine; Disease Progression; Female; Gene Expression Regulation, Neoplastic; Glycoproteins; Hepatectomy; Hepatocytes; Liver Neoplasms, Experimental; Liver Regeneration; Male; Mice; Mice, Inbred C57BL; Mice, Inbred CBA; Molecular Sequence Data; N-Acetylglucosaminyltransferases; Phenobarbital; Vascular Endothelial Growth Factor A | 2003 |